Inventor · disambiguated record
Detlef Stöckigt
Also filed as: STOCKIGT DETLEF · STÖCKIGT DETLEF
12 granted patents·14 pending applications·10 citations·filing 2011–2022
83Inventor score
Top patents by PatentIndex Score
26 records- 0191US11795164B22-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancerBAYER AG·Filed 2022·Granted Oct 24, 2023·3 cites·8 claims
- 0278US11304946B22-hetarylpyrimidine-4-carboxamides as aryl hydrocarbon receptor antagonistsBAYER AG·Filed 2018·Granted Apr 19, 2022·2 cites·11 claims
- 0374US11096934B2Compounds and methods useful for treating or preventing hematological cancersBROAD INST INC·Filed 2016·Granted Aug 24, 2021·1 cites·10 claims
- 0473US11459312B2Sulphur substituted 3-oxo-2,3-dihydropyridazine-4-carboxamidesBAYER AG·Filed 2018·Granted Oct 4, 2022·2 cites·12 claims
- 0568US11524944B22-phenylpyrimidine-4-carboxamides as AHR inhibitorsBAYER AG·Filed 2018·Granted Dec 13, 2022·1 cites·11 claims
- 0665US9663510B2Substituted triazolopyridines and their use as TTK inhibitorsBAYER IP GMBH·Filed 2012·Granted May 30, 2017·1 cites·27 claims
- 0760US2022016106A1Compounds and methods useful for treating or preventing hematological cancersBROAD INST INC·Filed 2021·Application pending·0 cites
- 0857US12478621B2Substituted aminoquinolones as dgkalpha inhibitors for immune activationBAYER AG·Filed 2020·Granted Nov 25, 2025·0 cites·17 claims
- 0950US2023064809A1Substituted aminoquinolones as dgkalpha inhibitors for immune activationBAYER AG·Filed 2020·Application pending·0 cites
- 1048US2023062100A1Substituted aminoquinolones as dgkalpha inhibitors for immune activationBAYER AG·Filed 2020·Application pending·0 cites
- 1148US2023113037A1[1,2,4]triazolo[1,5-c]quinazolin-5-aminesBAYER AG·Filed 2020·Application pending·0 cites
- 1247US9682995B2Amino-substituted isothiazolesBayer Pharma AG·Filed 2014·Granted Jun 20, 2017·0 cites·15 claims
- 1344US9586958B2Prodrug derivatives of substituted triazolopyridinesBayer Pharma AG·Filed 2014·Granted Mar 7, 2017·0 cites·14 claims
- 1444US2016207928A1Novel compounds for the treatment of cancerBayer Pharma AG·Filed 2014·Application pending·0 cites
- 1542US2016264568A1Substituted triazolopyridines having activity as mps-1 inhibitorsBayer Pharma AG·Filed 2014·Application pending·0 cites
- 1640US10894784B2Heteroarylbenzimidazole compoundsBayer Pharma AG·Filed 2016·Granted Jan 19, 2021·0 cites·15 claims
- 1737US2014120087A1TriazolopyridinesSCHULZE VOLKER·Filed 2012·Application pending·0 cites
- 1837US2016120854A1Pharmaceutical compositionsBAYER PHARMA AKTIENGESELl SCHAFT·Filed 2014·Application pending·0 cites
- 1937US2020246347A1Substituted Pyrrolopyridine-DerivativesBayer Pharma AG·Filed 2018·Application pending·0 cites
- 2034US9555022B2Substituted triazolopyridinesSCHULZE VOLKER·Filed 2011·Granted Jan 31, 2017·0 cites·15 claims
- 2133US2017217946A1Amino-substituted isoxazolesBayer Pharma AG·Filed 2015·Application pending·0 cites
- 2232US2017334899A1Amino-substituted isothiazolesBayer Pharma AG·Filed 2015·Application pending·0 cites
- 2328US10023539B2Aryl-cyanoguanidine compoundsBayer Pharma AG·Filed 2015·Granted Jul 17, 2018·0 cites·14 claims
- 2428US2017121322A1Bet-protein inhibiting 3,4-dihydropyrido[2,3-b]pyrazinones with meta-substituted aromatic amino- or ether groupsBayer Pharma AG·Filed 2015·Application pending·0 cites
- 2528US2018118722A1Novel aryl-cyanoguanidine compoundsBayer Pharma AG·Filed 2016·Application pending·0 cites
- 2626US2018099937A1Novel aryl-cyanoguanidine compoundsBayer Pharma AG·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Detlef Stöckigt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →